Validation of the 0/3-h algorithm and the APACE criteria to triage patients in the observe-zone

Le résumé fourni par la source

Abstract Background While high-sensitivity cardiac troponin testing has improved the early diagnosis of myocardial infarction, a substantial number of patients remain in the observe zone (OZ). Recent guidelines recommend rapid protocols and a 3h cardiac troponin measurement in patients triaged to the OZ of the ESC 0/1h-algorithm, but evidence on extended troponin testing times and their impact on diagnostic accuracy and outcomes remains sparse. Methods Patients with suspected acute coronary syndrome were enrolled in a single-centre observational study. The ESC 0/1-hour protocol was used for triage, with an optional 3rd troponin measurement at 3 hours or later, to evaluate the performance and safety of two validated triage algorithms used to resolve the OZ including a version that extends the time interval for the third troponin measurement beyond 3 hours. Results Of the 4,605 patients, 948 were triaged to the OZ (20.6%). The prevalence of NSTEMI within the OZ was 7.2%. 212 patients (22,3 % of OZ patients) had a third troponin measurement and were included in the comparative analysis. The overall sensitivity of the ESC 0/3-hour algorithm was lower at 69.4% compared to 86.1% (p=0.053) for the APACE algorithm, with both algorithms demonstrated similarly high negative predictive values (93.5% for ESC 0/3 and 87.5% for APACE, p=0.339). By definition, the ESC 0/3 hour algorithm categorises all patients directly into either rule-in or rule-out groups, eliminating the need for an OZ. In contrast, with the APACE algorithm 55.6% of patients remained in the OZ. Mortality rates in the OZ were similar across different timing protocols, with a 30-day mortality rate of 0.78% for patients with a third blood draw within 210 minutes (n=128) and 1.19% for those with the draw above 210 minutes (n=84). Over the 5-year follow-up, the overall mortality rates were 5.51% and 4.82% for the within-210 and above-210 groups, respectively, confirming the safety of the extended sampling interval. Conclusions Although the ESC 0/3-hour algorithm has a lower sensitivity than the APACE algorithm, it demonstrates higher effectiveness and similar safety, without leaving patients in the OZ. Extending the timing for the third troponin measurement beyond 3 hours proves to be effective and safe, supporting its implementation in clinical practice.Key findings.Patient flow.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.